| 25.47 2.95 (13.1%) | 03-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 31.85 |
1-year : | 37.2 |
| Resists | First : | 27.27 |
Second : | 31.85 |
| Pivot price | 22.98 |
|||
| Supports | First : | 22.85 |
Second : | 20.12 |
| MAs | MA(5) : | 21.98 |
MA(20) : | 23.09 |
| MA(100) : | 29.18  |
MA(250) : | 0 | |
| MACD | MACD : | -1.2 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 48.9 |
D(3) : | 24.8 |
| RSI | RSI(14): 53.9 |
|||
| 52-week | High : | 41.22 | Low : | 20.12 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HTFL ] has closed below upper band by 10.8%. Bollinger Bands are 34.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 22.62 - 22.73 | 22.73 - 22.82 |
| Low: | 20.76 - 20.88 | 20.88 - 20.99 |
| Close: | 22.31 - 22.52 | 22.52 - 22.71 |
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
Wed, 18 Mar 2026
HTFL insider sale: 9,725 shares planned; prior 35,399 shares sold (NASDAQ: HTFL) - Stock Titan
Fri, 13 Mar 2026
Capital International Investors Invests $43.67 Million in Heartflow, Inc. $HTFL - MarketBeat
Thu, 12 Mar 2026
Heartflow (HTFL) director exercises stock options to acquire 8,667 shares - Stock Titan
Thu, 12 Mar 2026
Heartflow (HTFL) CEO logs ESPP share award and pre-planned stock sale - Stock Titan
Fri, 06 Mar 2026
Heartflow (HTFL) director Julie Cullivan sells 9,122 shares in planned trade - Stock Titan
Thu, 13 Nov 2025
Heartflow Reports Third Quarter 2025 Financial Results - The Manila Times
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 85 (M) |
| Shares Float | 64 (M) |
| Held by Insiders | 2.5 (%) |
| Held by Institutions | 79 (%) |
| Shares Short | 4,560 (K) |
| Shares Short P.Month | 3,480 (K) |
| EPS | -1.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.04 |
| Profit Margin | -77.5 % |
| Operating Margin | -32.7 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 40.5 % |
| Gross Profit (p.s.) | 1.43 |
| Sales Per Share | 1.9 |
| EBITDA (p.s.) | -0.73 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -57 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -16.77 |
| PEG Ratio | 0 |
| Price to Book value | 8.24 |
| Price to Sales | 13.22 |
| Price to Cash Flow | -37.26 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|